Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desvenlafaxine for Frequent Episodic Tension-type Headache
NCT07359248Active, not recruiting
- Sponsor
- Tongji Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in tension-type headache (TTH) comparing Desvenlafaxine with placebo (2 arms). Primary endpoint: Days with tension-type headache at 12 weeks. Started Dec 2025; status: active, not recruiting.
02
Drugs
desvenlafaxine
03
Conditions
tension-type headache (TTH)
Beyond the preview
Go deeper on NCT07359248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07359248.